Next Steps: With LDT Final Rule Now Null, Industry Groups Urge Lab Managers and Pathologists to Advocate for Change

by Oscelle Boye, MBiomed | Apr 30, 2025 | CLIA-lca, CLIA-nir, Compliance-lca, Essential, FDA-lca, FDA-lir, FDA-nir, Lab Industry Advisor, Labs in Court-lca, Labs in Court-nir, LDTs-lir

CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight